Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	2.93T
Revenue (ttm)	1.46T
Net Income (ttm)	35.78B
Shares Out	73.04M
EPS (ttm)	489.47
PE Ratio	81.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	361,721
Average Volume	893,658
Open	40,100
Previous Close	40,100
Day's Range	39,300 - 40,150
52-Week Range	19,000 - 42,500
Beta	0.74
RSI	68.06
Earnings Date	Jan 27, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, phar...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 885
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.